Statistics

Total Visits

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period17

File Visits

Downloads
35543-24.pdf25

Select a period of time:

Number of views in the range

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period11

Number of downloads in the range

Downloads
35543-24.pdf4

Views

Views
November 20230
December 20231
January 20246
February 20240
March 20242
April 20241
May 20241
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • November 2023
    0
  • December 2023
    2
  • January 2024
    0
  • February 2024
    0
  • March 2024
    1
  • April 2024
    1
  • May 2024
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
 

Top countries by downloads

Downloads
United States4
 

Top cities views

Views
Boardman7
 

Top cities by downloads

Downloads